Expression analysis of BECN1 in acute myeloid leukemia: association with distinct cytogenetic and molecular abnormalities

International Journal of Laboratory Hematology
D Zare-AbdollahiL Gachkar

Abstract

In acute myeloid leukemia (AML), it has been shown that AML-derived cells often remain sensitive to autophagy-inducing stimuli, leading to the idea that harnessing the autophagy can be pertinent to AML cytotoxic therapy. Despite this promising notion, to date, there is no comprehensive study addressing autophagy-related genes expression status in AML. As a critical mediator, BECN1 influences the onset and advance of autophagy and several studies have pointed to the BECN1 recurrent allelic deletion and expression variation in a broad range of tumors. To explore this caveat, we chose this alteration-prone gene to investigate in our study. We have analyzed the expression status of BECN1 in a series of 128 de novo AML patients using real-time quantitative polymerase chain reaction (qRT-PCR). In our favorable subgroup, BECN1 expression did not alter (P = 0.301), but in intermediate and unfavorable patients, we have had BECN1 low expression compared to the normal controls (P = 0.008 and P < 0.001, respectively). We found evidence for the association of reduced expression of BECN1 with FLT3-ITD mutation (19 of 27 patients), monosomal karyotype (all of 11 patients), higher age, and WBC count. Overall, remarkable association of reduced ...Continue Reading

References

Jan 15, 2008·Cell·Beth Levine, Guido Kroemer
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Jul 23, 2008·Biochimica Et Biophysica Acta·Ashley R Winslow, David C Rubinsztein
Aug 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitri A BreemsBob Löwenberg
Aug 13, 2010·Cell Cycle·Alexandre PuissantPatrick Auberger
Jan 21, 2011·Nature·Beth LevineHerbert W Virgin
Feb 23, 2011·The Journal of Experimental Medicine·Monika MortensenAnna Katharina Simon
Apr 23, 2011·Cell Cycle·Alexander Scarth WatsonAnna Katharina Simon
Jan 19, 2013·Autophagy·Kara L ConwayRamnik J Xavier
Mar 15, 2013·Autophagy·Jun-Lin GuanJue Zhang
Mar 16, 2013·EMBO Molecular Medicine·Huize PanJuan Carlos Izpisua Belmonte
Nov 20, 2013·Medical Oncology·Davood Zare-AbdollahiMir Davood Omrani
Mar 25, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·V VinodSrinivas Gopala
Oct 7, 2014·Biochimica Et Biophysica Acta·Cecilia EvangelistiAlberto M Martelli
Jan 17, 2015·Hematology·Davood Zare-AbdollahiMir Davood Omrani
May 13, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antonia CagnettaMichele Cea

❮ Previous
Next ❯

Citations

Jan 16, 2018·Trauma, Violence & Abuse·April M ZeoliHannah Brenner
May 8, 2020·Diagnostic Pathology·Majid Ghayour-MobarhanMeysam Moghbeli
Mar 21, 2020·Cancers·Elise AasebøMaria Hernandez-Valladares

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.